Drug Shortage Report for HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)
Report ID | 169023 |
Drug Identification Number | 02303108 |
Brand name | HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) |
Common or Proper name | HEPARIN NA |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | HEPARIN SODIUM |
Strength(s) | 10000UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
Packaging size | 5ML 10LIVI |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-09-09 |
Estimated end date | 2022-09-16 |
Actual end date | 2022-09-09 |
Shortage status | Resolved |
Updated date | 2022-09-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-09-10 | English | Compare |
v4 | 2022-09-09 | French | Compare |
v3 | 2022-09-09 | English | Compare |
v2 | 2022-09-09 | French | Compare |
v1 | 2022-09-09 | English | Compare |
Showing 1 to 5 of 5